首页 > 最新文献

Gynecologic and Obstetric Investigation最新文献

英文 中文
Postoperative Reproductive Outcomes in Patients with Endometriosis-Associated Infertility: A Single-Center Retrospective Study. 子宫内膜异位症相关不孕症患者的术后生殖效果:单中心回顾性研究。
IF 2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-01-01 Epub Date: 2024-05-03 DOI: 10.1159/000539142
Khayal Gasimli, Dilara Akpinar, Bahar Gasimli, Annette Bachmann, Norbert Maczó, Rudy Leon De Wilde, Antoine Naem, Harald Krentel, Sven Becker, Morva Tahmasbi Rad

Objectives: Endometriosis is a chronic inflammatory disease known to contribute to infertility. Laparoscopic excision of endometriotic lesions represents a standard treatment modality for symptomatic women. Our study aims to assess the potential benefits of laparoscopic excision of endometriosis in patients experiencing infertility associated with the condition, as well as to define the clinical factors that may impact the cumulative pregnancy rate.

Design: In this retrospective analysis, a total of 102 patients with endometriosis-related infertility were enrolled.

Materials, setting, methods: All participants underwent reproductive surgery and were then categorized into two groups: those who conceived were assigned to group A, while those who did not were assigned to group B. The correlation between clinical factors and pregnancy rate was assessed using the log-rank test, and both univariate and multivariate analyses were conducted utilizing the Cox regression model.

Results: The median age of the patients was 33.5 years, with a median follow-up duration of 70 months. Throughout the study period, 71 patients (69.6%) conceived (group A), while the remaining 31 patients (30.4%) did not conceive (group B), irrespective of the use of Assisted-Reproduction Technologies. The Cox regression model revealed that factors such as the duration of infertility, presence of deep infiltrating endometriosis, bowel endometriosis, rASRM stages, pelvic adhesions, and recurrent disease negatively impacted postoperative conception rates. Conversely, complete excision and coagulation of endometriotic lesions, as well as ablation of ovarian endometriomas, emerged as independent positive predictive factors for postoperative clinical pregnancy.

Limitations: Limitations of this study is retrospective design of the study, as well as a small number of patients.

Conclusions: Complete excision of endometriosis during reproductive surgery may yield a positive effect and optimize the likelihood of pregnancy in patients with endometriosis-related infertility.

目的:子宫内膜异位症是一种慢性炎症性疾病,已知会导致不孕。腹腔镜子宫内膜异位症病灶切除术是针对有症状妇女的一种标准治疗方式。我们的研究旨在评估腹腔镜子宫内膜异位症切除术对不孕症患者的潜在益处,并确定可能影响累积妊娠率的临床因素:在这项回顾性分析中,共纳入了102名子宫内膜异位症相关不孕症患者:采用对数秩检验评估临床因素与妊娠率之间的相关性,并利用 Cox 回归模型进行单变量和多变量分析。结果 患者的中位年龄为 33.5 岁,中位随访时间为 70 个月。在整个研究期间,71 名患者(69.6%)受孕(A 组),其余 31 名患者(30.4%)未受孕(B 组),无论是否使用辅助生殖技术。Cox 回归模型显示,不孕时间长短、是否存在深部浸润性子宫内膜异位症、肠道子宫内膜异位症、rASRM 分期、盆腔粘连和复发疾病等因素对术后受孕率有负面影响。相反,子宫内膜异位症病灶的完全切除和凝固,以及卵巢子宫内膜瘤的消融,则是术后临床妊娠的独立积极预测因素:局限性:本研究为回顾性研究,患者人数较少:结论:在生殖手术中完全切除子宫内膜异位症可能会产生积极的效果,并提高子宫内膜异位症相关不孕症患者怀孕的可能性。
{"title":"Postoperative Reproductive Outcomes in Patients with Endometriosis-Associated Infertility: A Single-Center Retrospective Study.","authors":"Khayal Gasimli, Dilara Akpinar, Bahar Gasimli, Annette Bachmann, Norbert Maczó, Rudy Leon De Wilde, Antoine Naem, Harald Krentel, Sven Becker, Morva Tahmasbi Rad","doi":"10.1159/000539142","DOIUrl":"10.1159/000539142","url":null,"abstract":"<p><strong>Objectives: </strong>Endometriosis is a chronic inflammatory disease known to contribute to infertility. Laparoscopic excision of endometriotic lesions represents a standard treatment modality for symptomatic women. Our study aims to assess the potential benefits of laparoscopic excision of endometriosis in patients experiencing infertility associated with the condition, as well as to define the clinical factors that may impact the cumulative pregnancy rate.</p><p><strong>Design: </strong>In this retrospective analysis, a total of 102 patients with endometriosis-related infertility were enrolled.</p><p><strong>Materials, setting, methods: </strong>All participants underwent reproductive surgery and were then categorized into two groups: those who conceived were assigned to group A, while those who did not were assigned to group B. The correlation between clinical factors and pregnancy rate was assessed using the log-rank test, and both univariate and multivariate analyses were conducted utilizing the Cox regression model.</p><p><strong>Results: </strong>The median age of the patients was 33.5 years, with a median follow-up duration of 70 months. Throughout the study period, 71 patients (69.6%) conceived (group A), while the remaining 31 patients (30.4%) did not conceive (group B), irrespective of the use of Assisted-Reproduction Technologies. The Cox regression model revealed that factors such as the duration of infertility, presence of deep infiltrating endometriosis, bowel endometriosis, rASRM stages, pelvic adhesions, and recurrent disease negatively impacted postoperative conception rates. Conversely, complete excision and coagulation of endometriotic lesions, as well as ablation of ovarian endometriomas, emerged as independent positive predictive factors for postoperative clinical pregnancy.</p><p><strong>Limitations: </strong>Limitations of this study is retrospective design of the study, as well as a small number of patients.</p><p><strong>Conclusions: </strong>Complete excision of endometriosis during reproductive surgery may yield a positive effect and optimize the likelihood of pregnancy in patients with endometriosis-related infertility.</p>","PeriodicalId":12952,"journal":{"name":"Gynecologic and Obstetric Investigation","volume":" ","pages":"453-460"},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11633888/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140860037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Findings from the Use of Spinal Anesthesia in the Laparoscopic Treatment of Extrauterine Pregnancy: Could It Represent an Alternative to General Anesthesia? 在腹腔镜治疗宫外孕过程中使用脊髓麻醉的结果:脊髓麻醉能否替代全身麻醉?
IF 2.1 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-01-01 Epub Date: 2023-12-13 DOI: 10.1159/000535778
Luigi Della Corte, Maria Chiara Guarino, Michela Dell'Aquila, Mario Ascione, Serena Guerra, Rossella De Rosa, Annaclaudia Del Piano, Dario Bruzzese, Giuseppe Bifulco, Pierluigi Giampaolino

Introduction: Minimally invasive procedures performed in laparoscopy, such as salpingectomy for ectopic pregnancy, can be combined with a minimally invasive anesthesia. The aim of this study was to assess the feasibility and the intraoperative and postoperative outcomes of laparoscopic surgery for ectopic pregnancy under spinal anesthesia (SA) compared to general anesthesia (GA) from the point of view of the surgeon, anesthesiologist, and patient.

Methods: A retrospective cohort study was performed at DAI Materno Infantile of AOU Federico II of Naples, analyzing all medical records of women who met the inclusion criteria between April 2020 and April 2023. Eighty-two women (35 under SA in group A and 47 under GA in group B) undergone elective or emergency laparoscopic salpingectomy for ectopic tubal or ovarian pregnancy were included.

Results: Patients in group A reported less pain at 0 h (adjusted mean difference: -1.5; 95% CI: -2.3 to -0.7; p < 0.001) and after 6 h (adjusted mean difference: -1.1; 95% CI: -2.0 to -0.3; p = 0.01) while no statistically significant differences between the two groups at 12 and 24 h after surgery. No differences were observed among the type of analgesic and during the postoperative observation time, except for paracetamol at 0 h in group B. A faster resumption of bowel motility, patient's mobilization, and a shorter hospital stay were observed in group A compared to group B. Also greater odds of returning faster to daily activities emerged in group A (adjusted OR: 5.39; 95% CI: 1.77-16.37). A greater number of patients in group A were satisfied with the entire procedure compared to those of group B (33 [94.3%] vs. 37 [78.7%]). The general surgeon satisfaction was always very good or excellent in group A. Finally, all surgical steps were well tolerated in group A.

Conclusion: In specific settings, SA is a feasible and safe procedure for the laparoscopic treatment of ectopic pregnancy.

导言腹腔镜微创手术(如宫外孕输卵管切除术)可与微创麻醉相结合。本研究旨在从外科医生、麻醉师和患者的角度评估脊髓麻醉(SA)与全身麻醉(GA)下腹腔镜异位妊娠手术的可行性以及术中和术后效果:那不勒斯费德里科二世医院(AOU Federico II)妇幼保健院(DAI Materno Infantile)进行了一项回顾性队列研究,分析了2020年4月至2023年4月期间符合纳入标准的妇女的所有医疗记录。研究共纳入了82名因输卵管或卵巢异位妊娠而接受择期或急诊腹腔镜输卵管切除术的女性(A组35人接受SA手术,B组47人接受GA手术):结果:A 组患者在 0 h 时的疼痛较轻(调整后的平均差异为-1.5;95% CI):结果:A 组患者在 0 h 后的疼痛较轻(调整后的平均差异:-1.5;95% CI:-2.3 至 -0.7;p):在特定情况下,腹腔镜手术治疗异位妊娠是一种可行且安全的方法。
{"title":"Findings from the Use of Spinal Anesthesia in the Laparoscopic Treatment of Extrauterine Pregnancy: Could It Represent an Alternative to General Anesthesia?","authors":"Luigi Della Corte, Maria Chiara Guarino, Michela Dell'Aquila, Mario Ascione, Serena Guerra, Rossella De Rosa, Annaclaudia Del Piano, Dario Bruzzese, Giuseppe Bifulco, Pierluigi Giampaolino","doi":"10.1159/000535778","DOIUrl":"10.1159/000535778","url":null,"abstract":"<p><strong>Introduction: </strong>Minimally invasive procedures performed in laparoscopy, such as salpingectomy for ectopic pregnancy, can be combined with a minimally invasive anesthesia. The aim of this study was to assess the feasibility and the intraoperative and postoperative outcomes of laparoscopic surgery for ectopic pregnancy under spinal anesthesia (SA) compared to general anesthesia (GA) from the point of view of the surgeon, anesthesiologist, and patient.</p><p><strong>Methods: </strong>A retrospective cohort study was performed at DAI Materno Infantile of AOU Federico II of Naples, analyzing all medical records of women who met the inclusion criteria between April 2020 and April 2023. Eighty-two women (35 under SA in group A and 47 under GA in group B) undergone elective or emergency laparoscopic salpingectomy for ectopic tubal or ovarian pregnancy were included.</p><p><strong>Results: </strong>Patients in group A reported less pain at 0 h (adjusted mean difference: -1.5; 95% CI: -2.3 to -0.7; p &lt; 0.001) and after 6 h (adjusted mean difference: -1.1; 95% CI: -2.0 to -0.3; p = 0.01) while no statistically significant differences between the two groups at 12 and 24 h after surgery. No differences were observed among the type of analgesic and during the postoperative observation time, except for paracetamol at 0 h in group B. A faster resumption of bowel motility, patient's mobilization, and a shorter hospital stay were observed in group A compared to group B. Also greater odds of returning faster to daily activities emerged in group A (adjusted OR: 5.39; 95% CI: 1.77-16.37). A greater number of patients in group A were satisfied with the entire procedure compared to those of group B (33 [94.3%] vs. 37 [78.7%]). The general surgeon satisfaction was always very good or excellent in group A. Finally, all surgical steps were well tolerated in group A.</p><p><strong>Conclusion: </strong>In specific settings, SA is a feasible and safe procedure for the laparoscopic treatment of ectopic pregnancy.</p>","PeriodicalId":12952,"journal":{"name":"Gynecologic and Obstetric Investigation","volume":" ","pages":"41-49"},"PeriodicalIF":2.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138803345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Neutrophil-Lymphocytes Ratio in the Prognosis of CIN2+ Recurrence after Excisional Treatment. 中性粒细胞-淋巴细胞比值(NLR)在切除治疗后 CIN2+ 2 复发预后中的作用。
IF 2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-01-01 Epub Date: 2024-03-18 DOI: 10.1159/000534790
Mattia Dominoni, Amelia Barcellini, Marianna Francesca Pasquali, Annalisa De Silvestri, Virginia Valeria Ferretti, Stefania Cesari, Giacomo Fiandrino, Ester Orlandi, Barbara Gardella

Objectives: The main risk factor involved in CIN2+ recurrence after treatment is the HPV persistent infection. The dysregulation of the immune system permits only HR-HPVs to become persistent infections, to promote cancer development, and to increase the risk of recurrence after treatment. Therefore, there is a shift to a Th2-type cytokine pattern during the carcinogenesis pathway; for this reason, the neutrophil-lymphocytes ratio (NLR) could be a marker of this immunological change. The study aimed to analyse the predictive role of NLR in the recurrence of high-grade CIN (CIN2+) after excisional treatment in a real-world life setting of patients treated for CIN2+.

Design: This study wascross-sectional study.

Participants/materials, setting, methods: We examined a retrospective database of 444 patients, who attended the colposcopy service of our department from 2011 to 2020 due to an abnormal screening Pap smear, and we compared the clinical characteristics to NLR performed at the time of diagnosis. All analysed patients were treated according to an established protocol (colposcopy every 6 months for the first 2 years and every year for over 3 years) and HPV-DNA test and cervical biopsy were performed at entry and the end of follow-up. All patients underwent a blood sample examination, including complete white blood cell counts and collecting neutrophil and lymphocyte values expressed as 103/mL.

Results: The sensitivity (SE) and specificity (SP) of the NLR cut-off point of 1.34 for the diagnosis of CIN2+ recurrence were 0.76 and 0.67, respectively. We found that CIN2+ recurrences were significantly higher in patients with NLR <1.34 (3.7% vs. 0.6%, p = 0.033) and the 5-year recurrence-free survival was higher in patients with NLR ≥1.34 (97% vs. 93%, p = 0.030).

Limitations: Firstly, the retrospective analysis and low incidence of recurrence may limit the conclusions. Second, for the retrospective design of the study, we did not take into consideration the patient's comorbidities and habits (smoking) that may influence the NLR. On the other hand, the median duration of follow-up in our study was 26 months (IQR: 22-31), which fully reflects the incidence of recurrences.

Conclusions: It is well known that CIN2+ lesions are sustained by deregulation of the immune system caused by persistent HPV infection, which may lead to cervical cancer. Among the actors underlying dysregulation of immunity, lymphocytes are involved in the permission of persistent infection and for this reason, NRL could be a reliable and cost-effective biomarker in predicting the risk of recurrence, especially for high-grade cervical lesions.

目的:CIN2+ 治疗后复发的主要风险因素是 HPV 持续感染。免疫系统失调只允许 HR-HPV 持续感染,促进癌症发展,增加治疗后复发的风险。因此,在癌变过程中,细胞因子模式向 Th2 型转变;为此,中性粒细胞-淋巴细胞比值(NLR)可作为这种免疫学变化的标志物。本研究的目的是在现实生活中对接受过 CIN2+ 治疗的患者进行切除治疗后,分析 NLR 对高级别 CIN(CIN2+)复发的预测作用:我们对 2011 年至 2020 年期间因子宫颈抹片筛查异常而到我科阴道镜服务处就诊的 444 名患者的回顾性数据库进行了研究,并将其临床特征与诊断时进行的 NLR 进行了比较。所有接受分析的患者都按照既定方案接受了治疗(头两年每 6 个月接受一次阴道镜检查,三年后每年接受一次),并在入院时和随访结束时进行了 HPV DNA 检测和宫颈活检。所有患者都接受了血样检查,包括全血细胞计数和以 103/ml 表示的中性粒细胞和淋巴细胞收集值。结果 NLR截断点1.34对诊断CIN2+复发的敏感性(SE)和特异性(SP)分别为0.76和0.67。我们发现,NLR<1.34的患者CIN2+复发率明显更高(3.7% vs. 0.6%,P=0.033),NLR≥1.34的患者5年无复发生存率更高(97% vs. 93%,P=0.030)。局限性 首先,回顾性分析和较低的复发率可能会限制结论的得出。其次,由于是回顾性研究,我们没有考虑患者的合并症和生活习惯(吸烟),这可能会影响 NLR。另一方面,我们研究的中位随访时间为 26 个月(IQR 22-31),这充分反映了复发的发生率。结论 众所周知,CIN2+病变是由持续的人乳头瘤病毒感染导致的免疫系统失调引起的,这可能会导致宫颈癌。因此,NRL 可以作为预测复发风险(尤其是高级别宫颈病变的复发风险)的可靠而经济的生物标志物。
{"title":"The Role of Neutrophil-Lymphocytes Ratio in the Prognosis of CIN2+ Recurrence after Excisional Treatment.","authors":"Mattia Dominoni, Amelia Barcellini, Marianna Francesca Pasquali, Annalisa De Silvestri, Virginia Valeria Ferretti, Stefania Cesari, Giacomo Fiandrino, Ester Orlandi, Barbara Gardella","doi":"10.1159/000534790","DOIUrl":"10.1159/000534790","url":null,"abstract":"<p><strong>Objectives: </strong>The main risk factor involved in CIN2+ recurrence after treatment is the HPV persistent infection. The dysregulation of the immune system permits only HR-HPVs to become persistent infections, to promote cancer development, and to increase the risk of recurrence after treatment. Therefore, there is a shift to a Th2-type cytokine pattern during the carcinogenesis pathway; for this reason, the neutrophil-lymphocytes ratio (NLR) could be a marker of this immunological change. The study aimed to analyse the predictive role of NLR in the recurrence of high-grade CIN (CIN2+) after excisional treatment in a real-world life setting of patients treated for CIN2+.</p><p><strong>Design: </strong>This study wascross-sectional study.</p><p><strong>Participants/materials, setting, methods: </strong>We examined a retrospective database of 444 patients, who attended the colposcopy service of our department from 2011 to 2020 due to an abnormal screening Pap smear, and we compared the clinical characteristics to NLR performed at the time of diagnosis. All analysed patients were treated according to an established protocol (colposcopy every 6 months for the first 2 years and every year for over 3 years) and HPV-DNA test and cervical biopsy were performed at entry and the end of follow-up. All patients underwent a blood sample examination, including complete white blood cell counts and collecting neutrophil and lymphocyte values expressed as 103/mL.</p><p><strong>Results: </strong>The sensitivity (SE) and specificity (SP) of the NLR cut-off point of 1.34 for the diagnosis of CIN2+ recurrence were 0.76 and 0.67, respectively. We found that CIN2+ recurrences were significantly higher in patients with NLR &lt;1.34 (3.7% vs. 0.6%, p = 0.033) and the 5-year recurrence-free survival was higher in patients with NLR ≥1.34 (97% vs. 93%, p = 0.030).</p><p><strong>Limitations: </strong>Firstly, the retrospective analysis and low incidence of recurrence may limit the conclusions. Second, for the retrospective design of the study, we did not take into consideration the patient's comorbidities and habits (smoking) that may influence the NLR. On the other hand, the median duration of follow-up in our study was 26 months (IQR: 22-31), which fully reflects the incidence of recurrences.</p><p><strong>Conclusions: </strong>It is well known that CIN2+ lesions are sustained by deregulation of the immune system caused by persistent HPV infection, which may lead to cervical cancer. Among the actors underlying dysregulation of immunity, lymphocytes are involved in the permission of persistent infection and for this reason, NRL could be a reliable and cost-effective biomarker in predicting the risk of recurrence, especially for high-grade cervical lesions.</p>","PeriodicalId":12952,"journal":{"name":"Gynecologic and Obstetric Investigation","volume":" ","pages":"295-303"},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140158020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical Management of Gestational Trophoblastic Disease. 妊娠滋养细胞疾病的外科治疗。
IF 2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-01-01 Epub Date: 2023-10-03 DOI: 10.1159/000534065
Leonoor Coopmans, Agnes Larsson, Ulrika Joneborg, Christianne Lok, Nienke van Trommel

Background: Gestational trophoblastic disease (GTD) is a rare pregnancy-related condition consisting of premalignant and malignant forms arising from proliferation of trophoblastic cells. The malignant forms are collectively referred to as gestational trophoblastic neoplasia (GTN) and are highly sensitive to chemotherapy. However, surgical procedures remain indispensable in the diagnosis and treatment of GTD.

Objectives: The aim of this review was to summarize surgical interventions in the treatment of GTD and GTN. We reviewed indications, efficacy, possible complications, and oncological outcomes of surgery.

Methods: Three searches were performed in the databases of PubMed, Embase, and the Cochrane Library to create an up-to-date overview of existing literature on the following subjects: (1) the role of primary hysterectomy in GTD and GTN; (2) the role of second curettage in GTD and GTN; (3) fertility sparing surgery in GTN; (4) surgical management of metastases. Included articles originated from the time period 1952-2022. Articles written in English, Spanish, and French were included.

Outcomes: Thirty-eight articles were found and selected. Surgical evacuation through suction curettage is most used and advised in the treatment of GTD. A second curettage could be beneficial in patients with low hCG levels and low FIGO scores. In women who have completed their families, primary hysterectomy might be considered as the risk of subsequent GTN is lower than after suction curettage. In case of the rare forms of GTN (epithelioid trophoblastic tumor or placental site trophoblastic tumor) surgical tumor resection remains the most important step in treatment. Data on fertility sparing surgery in GTN are scarce and this treatment should be considered experimental.

Conclusion and outlook: Surgery remains an important part of treatment of GTD and is sometimes indispensable to achieve curation. Further collection of evidence is needed to determine treatment steps.

背景妊娠滋养细胞病(GTD)是一种罕见的妊娠相关疾病,由滋养层细胞增殖引起的癌前和恶性形式组成。恶性形式统称为妊娠滋养细胞增生症(GTN),对化疗高度敏感。然而,在GTD的诊断和治疗中,外科手术仍然是必不可少的。目的本综述旨在总结GTD和GTN的外科干预措施。我们回顾了手术的适应症、疗效、可能的并发症和肿瘤学结果。方法在PubMed、Embase和Cochrane图书馆的数据库中进行三次检索,以创建关于以下主题的现有文献的最新综述:1。初次子宫切除术在GTD和GTN2中的作用。第二次刮除术在GTD和GTN3中的作用。GTN保留生育能力的手术4。转移瘤的外科治疗。收录的文章来源于1952-2022年。其中包括用英语、西班牙语和法语撰写的文章。结果发现并选择了38篇文章。在GTD的治疗中,通过刮宫进行手术排空是最常用和建议的。第二次刮除术对hCG水平低、FIGO评分低的患者可能有益。对于已经完成家庭的女性,初次子宫切除术可能被认为是因为后续GTN的风险低于刮除术后。在罕见形式的GTN(上皮样滋养细胞肿瘤(ETT)或胎盘部位滋养细胞瘤(PSTT))的情况下,手术切除肿瘤仍然是治疗中最重要的步骤。GTN保留生育能力手术的数据很少,这种治疗应该被视为实验性的。结论和展望外科手术仍然是GTD治疗的重要组成部分,有时对实现治疗是必不可少的。需要进一步收集证据来确定治疗步骤。
{"title":"Surgical Management of Gestational Trophoblastic Disease.","authors":"Leonoor Coopmans, Agnes Larsson, Ulrika Joneborg, Christianne Lok, Nienke van Trommel","doi":"10.1159/000534065","DOIUrl":"10.1159/000534065","url":null,"abstract":"<p><strong>Background: </strong>Gestational trophoblastic disease (GTD) is a rare pregnancy-related condition consisting of premalignant and malignant forms arising from proliferation of trophoblastic cells. The malignant forms are collectively referred to as gestational trophoblastic neoplasia (GTN) and are highly sensitive to chemotherapy. However, surgical procedures remain indispensable in the diagnosis and treatment of GTD.</p><p><strong>Objectives: </strong>The aim of this review was to summarize surgical interventions in the treatment of GTD and GTN. We reviewed indications, efficacy, possible complications, and oncological outcomes of surgery.</p><p><strong>Methods: </strong>Three searches were performed in the databases of PubMed, Embase, and the Cochrane Library to create an up-to-date overview of existing literature on the following subjects: (1) the role of primary hysterectomy in GTD and GTN; (2) the role of second curettage in GTD and GTN; (3) fertility sparing surgery in GTN; (4) surgical management of metastases. Included articles originated from the time period 1952-2022. Articles written in English, Spanish, and French were included.</p><p><strong>Outcomes: </strong>Thirty-eight articles were found and selected. Surgical evacuation through suction curettage is most used and advised in the treatment of GTD. A second curettage could be beneficial in patients with low hCG levels and low FIGO scores. In women who have completed their families, primary hysterectomy might be considered as the risk of subsequent GTN is lower than after suction curettage. In case of the rare forms of GTN (epithelioid trophoblastic tumor or placental site trophoblastic tumor) surgical tumor resection remains the most important step in treatment. Data on fertility sparing surgery in GTN are scarce and this treatment should be considered experimental.</p><p><strong>Conclusion and outlook: </strong>Surgery remains an important part of treatment of GTD and is sometimes indispensable to achieve curation. Further collection of evidence is needed to determine treatment steps.</p>","PeriodicalId":12952,"journal":{"name":"Gynecologic and Obstetric Investigation","volume":" ","pages":"214-229"},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41173855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expression of Concern. 表达关切。
IF 2.1 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-01-01 Epub Date: 2024-01-19 DOI: 10.1159/000535975
{"title":"Expression of Concern.","authors":"","doi":"10.1159/000535975","DOIUrl":"10.1159/000535975","url":null,"abstract":"","PeriodicalId":12952,"journal":{"name":"Gynecologic and Obstetric Investigation","volume":" ","pages":"71"},"PeriodicalIF":2.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139512208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the Diagnostic Potential of EPB41L3 Methylation in Cervical Cancer and Precancerous Lesions: A Systematic Review and Meta-Analysis. 探索 EPB41L3 甲基化在宫颈癌和癌前病变中的诊断潜力:系统综述和荟萃分析。
IF 2.1 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-01-01 Epub Date: 2023-12-11 DOI: 10.1159/000535563
Ying Sha, Yunyun Liu, Xiaoxiao Yang, Jing Wang, Ruohan Zhang, Fangrong Shen

Objective: This meta-analysis aimed to comprehensively evaluate the diagnostic use of erythrocyte membrane protein band 4.1like3 (EPB41L3) methylation detection in cervical cancer (CC) and its precancerous lesions.

Methods: CNKI, Wanfang, Cochrane Library, PubMed, and Ovid databases were searched using a combination of subject headings and free words. Pertinent data were retrieved after screening for inclusion and exclusion criteria, and the quality of the included studies was evaluated using QUADAS-2 criteria. The appropriate software was used for heterogeneity analysis and combined effect size calculation. Additionally, sensitivity analysis was used to evaluate the robustness of the combined results, and meta-regression and subgroup analysis were conducted to investigate the origins of heterogeneity.

Results: This meta-analysis included six studies, including 525 healthy individuals, 182 cervical intraepithelial neoplasia 1 (CIN1) samples, 182 CIN2 samples, 281 CIN3 samples, and 226 CC samples. EPB41L3 methylation detection for CIN2 and above lesions demonstrated combined sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, diagnostic odds ratio (DOR), and the area under the curve of the comprehensive receiver operating characteristic curve of 0.67, 0.76, 3.19, 0.41, 7.60, and 0.80, respectively; CIN3 and above lesions demonstrated these evaluations at 0.73, 0.84, 4.35, 0.33, 23.94, and 0.90, respectively. Meta-regression analysis revealed that the population, time, sample type, detection method, literature quality, and sample size were not significant sources of heterogeneity affecting the combined diagnostic efficacy of CIN2 and above lesions (p > 0.05). Subgroup analysis revealed higher combined diagnostic values of CIN2 and above lesions in retrospective studies, tissue samples, and Chinese populations, with DORs of 41.03, 14.59, and 13.70, respectively.

Conclusion: EPB41L3 methylation demonstrated a relatively low diagnostic performance in CC and precancerous lesions. However, it merits further investigation as a potential biomarker. Integrating it with multiple gene detection, human papillomavirus testing, and ThinPrep liquid-based cytology test examination is recommended to explore improved diagnostic strategies for CC and its precancerous lesions.

目的:本荟萃分析旨在全面评估红细胞膜蛋白带4.1like3(EPB41L3)甲基化检测在宫颈癌及其癌前病变中的诊断应用:采用主题词和自由词相结合的方法检索了 CNKI、万方数据库、Cochrane 图书馆、Pubmed 和 Ovid 数据库。根据纳入和排除标准进行筛选后,检索到相关数据,并使用 QUADAS-2 标准对纳入研究的质量进行评估。使用适当的软件进行异质性分析和综合效应大小计算。此外,还使用了敏感性分析来评估合并结果的稳健性,并进行了元回归和亚组分析来研究异质性的来源:这项荟萃分析纳入了六项研究,包括525名健康人、182份宫颈上皮内瘤变1(CIN1)样本、182份CIN2样本、281份CIN3样本和226份宫颈癌样本。CIN2及以上病变的EPB41L3甲基化检测的综合灵敏度、特异性、阳性似然比、阴性似然比、诊断几率比(DOR)和综合接收者操作特征曲线下面积分别为0.67、0.76、3.19、0.41、7.60和0.80,CIN3及以上病变的综合灵敏度、特异性、阳性似然比、阴性似然比、诊断几率比(DOR)和综合接收者操作特征曲线下面积分别为0.73、0.84、4.35、0.33、23.94和0.90。元回归分析显示,人群、时间、样本类型、检测方法、文献质量和样本大小不是影响 CIN2 及以上病变综合诊断效果的显著异质性来源(P > 0.05)。亚组分析显示,回顾性研究、组织样本和中国人群的CIN2及以上病变综合诊断价值更高,DOR分别为41.03、14.59和13.70:结论:EPB41L3甲基化对宫颈癌和癌前病变的诊断率相对较低。然而,它作为一种潜在的生物标记物值得进一步研究。建议将其与多基因检测、人乳头瘤病毒检测和 ThinPrep 液基细胞学检验检查结合起来,探索改进宫颈癌及其癌前病变的诊断策略:宫颈癌;EPB41L3;甲基化;诊断;Meta 分析。
{"title":"Exploring the Diagnostic Potential of EPB41L3 Methylation in Cervical Cancer and Precancerous Lesions: A Systematic Review and Meta-Analysis.","authors":"Ying Sha, Yunyun Liu, Xiaoxiao Yang, Jing Wang, Ruohan Zhang, Fangrong Shen","doi":"10.1159/000535563","DOIUrl":"10.1159/000535563","url":null,"abstract":"<p><strong>Objective: </strong>This meta-analysis aimed to comprehensively evaluate the diagnostic use of erythrocyte membrane protein band 4.1like3 (EPB41L3) methylation detection in cervical cancer (CC) and its precancerous lesions.</p><p><strong>Methods: </strong>CNKI, Wanfang, Cochrane Library, PubMed, and Ovid databases were searched using a combination of subject headings and free words. Pertinent data were retrieved after screening for inclusion and exclusion criteria, and the quality of the included studies was evaluated using QUADAS-2 criteria. The appropriate software was used for heterogeneity analysis and combined effect size calculation. Additionally, sensitivity analysis was used to evaluate the robustness of the combined results, and meta-regression and subgroup analysis were conducted to investigate the origins of heterogeneity.</p><p><strong>Results: </strong>This meta-analysis included six studies, including 525 healthy individuals, 182 cervical intraepithelial neoplasia 1 (CIN1) samples, 182 CIN2 samples, 281 CIN3 samples, and 226 CC samples. EPB41L3 methylation detection for CIN2 and above lesions demonstrated combined sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, diagnostic odds ratio (DOR), and the area under the curve of the comprehensive receiver operating characteristic curve of 0.67, 0.76, 3.19, 0.41, 7.60, and 0.80, respectively; CIN3 and above lesions demonstrated these evaluations at 0.73, 0.84, 4.35, 0.33, 23.94, and 0.90, respectively. Meta-regression analysis revealed that the population, time, sample type, detection method, literature quality, and sample size were not significant sources of heterogeneity affecting the combined diagnostic efficacy of CIN2 and above lesions (p &gt; 0.05). Subgroup analysis revealed higher combined diagnostic values of CIN2 and above lesions in retrospective studies, tissue samples, and Chinese populations, with DORs of 41.03, 14.59, and 13.70, respectively.</p><p><strong>Conclusion: </strong>EPB41L3 methylation demonstrated a relatively low diagnostic performance in CC and precancerous lesions. However, it merits further investigation as a potential biomarker. Integrating it with multiple gene detection, human papillomavirus testing, and ThinPrep liquid-based cytology test examination is recommended to explore improved diagnostic strategies for CC and its precancerous lesions.</p>","PeriodicalId":12952,"journal":{"name":"Gynecologic and Obstetric Investigation","volume":" ","pages":"1-10"},"PeriodicalIF":2.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138803343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cell Cycle-Related Centromere Protein F Deficiency Suppresses Ovarian Cancer Cell Growth by Inducing Ferroptosis. 细胞周期相关的中心粒蛋白 F 缺乏可通过诱导铁变态反应抑制卵巢癌细胞的生长。
IF 2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-01-01 Epub Date: 2024-05-09 DOI: 10.1159/000539235
Xinyue Liu, Li Guo, Yuping Suo, XinHui Tang, Ting Zhu, Tiannan Zhao, Weina Zhang, Ping Zhang

Objectives: This study aimed to investigate the involvement of the cell cycle-related protein centromere protein F (CENPF) in the development of ovarian cancer (OC) and explored its relationship with ferroptosis.

Design: The databases were analysed to identify differential expression of cell cycle-related proteins between individuals with OC and normal individuals. Immunohistochemistry and statistical analysis were conducted on ovarian tissues obtained from 40 patients with epithelial OC and 20 normal individuals. In vitro experiments were performed using SKOV3 and HEY epithelial OC cell lines.

Participants/materials, setting, methods: The mRNA microarray dataset, consisting of GSE14001, GSE54388, GSE40595, and GSE14407, was downloaded from the Gene Expression Omnibus (GEO) database to investigate the genes associated with cell cycle regulation in OC cells. CENPF was selected as the subject of study through differential analysis.Assessed the expression of CENPF in both OC patients and normal ovarian tissues using immunohistochemistry. Lentivirus infection was employed to downregulate CENPF expression, and subsequent experiments including Cell Counting Kit-8 assay, cell cycle analysis, transwell assay, and wound-healing assay were conducted to investigate the effects of CENPF on proliferation, invasion, migration, and cell cycle regulation in OC cells. The reactive oxygen species (ROS) and the malondialdehyde (MDA) assays were performed to assess the involvement of CENPF in cellular redox reactions. Western blot analysis was conducted to examine the expression levels of ferroptosis-related proteins (GPX4, SLC7A11, DMT1, and protein 53 [p53]).

Results: By querying and integrating cell cycle-related genes from the GEO database, in silico analyses using The Cancer Genome Atlas database combined with immunohistochemical studies, we discovered that CENPF is upregulated in OC tissues and is related to survival. Downregulation of CENPF inhibited biological function of OC cells, increased intracellular ROS and MDA levels, and downregulated the GPX4 protein and the SLC7A11/xCT protein, but upregulated the DMT1 protein and the tumour p53 expression to induce ferroptosis.

Limitations: This study did not investigate ferroptosis-related studies following CENPF overexpression, and the findings have not been validated in animal studies.

Conclusions: Our findings demonstrated that the deficiency of CENPF played a crucial anti-oncogenic role in the progression of OC through the mechanism of ferroptosis.

研究目的本研究旨在调查细胞周期相关蛋白中心粒蛋白F(CENPF)参与卵巢癌(OC)发病的情况,并探讨其与铁变态反应的关系:分析数据库以确定卵巢癌患者与正常人之间细胞周期相关蛋白的差异表达。对 40 名上皮性卵巢癌患者和 20 名正常人的卵巢组织进行免疫组化和统计分析。使用 SKOV3 和 HEY 上皮性卵巢癌细胞系进行了体外实验:从基因表达总库(GEO)数据库下载了由 GSE14001、GSE54388、GSE40595 和 GSE14407 组成的 mRNA 微阵列数据集,以研究卵巢癌细胞中与细胞周期调控相关的基因。通过差异分析,选择 CENPF 作为研究对象。用免疫组化方法评估 CENPF 在卵巢癌(OC)患者和正常卵巢组织中的表达。利用慢病毒感染下调 CENPF 的表达,随后进行细胞计数试剂盒-8(CCK-8)检测、细胞周期分析、transwell 检测和伤口愈合检测等实验,研究 CENPF 对 OC 细胞增殖、侵袭、迁移和细胞周期调控的影响。通过活性氧(ROS)和丙二醛(MDA)检测来评估 CENPF 参与细胞氧化还原反应的情况。此外,还进行了 Western 印迹分析,以检测铁突变相关蛋白(GPX4、SLC7A11、DMT1 和 P53)的表达水平:结果:通过查询和整合 GEO 数据库中的细胞周期相关基因,利用癌症基因组图谱(TCGA)数据库结合免疫组化研究进行硅学分析,我们发现 CENPF 在卵巢癌组织中上调,并与存活率有关。CENPF的下调抑制了OC细胞的生物学功能,增加了细胞内ROS和MDA水平,下调了GPX4蛋白和SLC7A11/xCT蛋白,但上调了DMT1蛋白和肿瘤蛋白53(P53)蛋白的表达,从而诱导铁变态反应:局限性:本研究未对CENPF过表达后的铁变态反应相关研究进行调查,研究结果也未在动物实验中得到验证:我们的研究结果表明,CENPF的缺乏通过铁变态反应机制在OC的进展过程中起到了关键的抗癌作用。
{"title":"Cell Cycle-Related Centromere Protein F Deficiency Suppresses Ovarian Cancer Cell Growth by Inducing Ferroptosis.","authors":"Xinyue Liu, Li Guo, Yuping Suo, XinHui Tang, Ting Zhu, Tiannan Zhao, Weina Zhang, Ping Zhang","doi":"10.1159/000539235","DOIUrl":"10.1159/000539235","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to investigate the involvement of the cell cycle-related protein centromere protein F (CENPF) in the development of ovarian cancer (OC) and explored its relationship with ferroptosis.</p><p><strong>Design: </strong>The databases were analysed to identify differential expression of cell cycle-related proteins between individuals with OC and normal individuals. Immunohistochemistry and statistical analysis were conducted on ovarian tissues obtained from 40 patients with epithelial OC and 20 normal individuals. In vitro experiments were performed using SKOV3 and HEY epithelial OC cell lines.</p><p><strong>Participants/materials, setting, methods: </strong>The mRNA microarray dataset, consisting of GSE14001, GSE54388, GSE40595, and GSE14407, was downloaded from the Gene Expression Omnibus (GEO) database to investigate the genes associated with cell cycle regulation in OC cells. CENPF was selected as the subject of study through differential analysis.Assessed the expression of CENPF in both OC patients and normal ovarian tissues using immunohistochemistry. Lentivirus infection was employed to downregulate CENPF expression, and subsequent experiments including Cell Counting Kit-8 assay, cell cycle analysis, transwell assay, and wound-healing assay were conducted to investigate the effects of CENPF on proliferation, invasion, migration, and cell cycle regulation in OC cells. The reactive oxygen species (ROS) and the malondialdehyde (MDA) assays were performed to assess the involvement of CENPF in cellular redox reactions. Western blot analysis was conducted to examine the expression levels of ferroptosis-related proteins (GPX4, SLC7A11, DMT1, and protein 53 [p53]).</p><p><strong>Results: </strong>By querying and integrating cell cycle-related genes from the GEO database, in silico analyses using The Cancer Genome Atlas database combined with immunohistochemical studies, we discovered that CENPF is upregulated in OC tissues and is related to survival. Downregulation of CENPF inhibited biological function of OC cells, increased intracellular ROS and MDA levels, and downregulated the GPX4 protein and the SLC7A11/xCT protein, but upregulated the DMT1 protein and the tumour p53 expression to induce ferroptosis.</p><p><strong>Limitations: </strong>This study did not investigate ferroptosis-related studies following CENPF overexpression, and the findings have not been validated in animal studies.</p><p><strong>Conclusions: </strong>Our findings demonstrated that the deficiency of CENPF played a crucial anti-oncogenic role in the progression of OC through the mechanism of ferroptosis.</p>","PeriodicalId":12952,"journal":{"name":"Gynecologic and Obstetric Investigation","volume":" ","pages":"424-436"},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140897901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety, Efficacy, and Cost-effectiveness of Organ Suspension in Laparoscopic Gynecologic Surgery: A Retrospective Cohort Study to Validate an Innovative Technique: Laparoscopic Organ Suspension sec. Angioni. 腹腔镜妇科手术中器官悬吊的安全性、有效性和成本效益。一项验证创新技术的回顾性队列研究:腹腔镜器官悬吊术。Angioni.
IF 2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-01-01 Epub Date: 2024-05-02 DOI: 10.1159/000538787
Stefano Angioni, Stefania Saponara, Gianmarco D'Ancona, Gilda Sicilia, Maurizio Nicola D'Alterio, Salvatore Giovanni Vitale

Objectives: This study aims to evaluate the safety, efficacy, and cost-effectiveness of the Laparoscopic Organ Suspension (OS) sec. Angioni, an innovative approach to transient OS in laparoscopic gynecological procedures. Recognizing the need to enhance surgical site access and overcome limitations of existing organ retraction methods, the study investigates a novel, in-theater constructed OS device.

Design: This retrospective observational study was conducted from March 2019 to May 2021 and included 330 patients who underwent multiport or single-site-port laparoscopic surgery employing Angioni's technique for transient pelvic OS.

Participants/materials, setting, methods: Participants included individuals undergoing surgery for conditions such as endometriosis, ovarian cancer, endometrial cancer, pelvic prolapse, and benign ovarian cysts. The Laparoscopic OS sec. Angioni utilizes a segment of a Foley catheter connected to a Polyglactin suture to provide adjustable tension, minimizing the need for reconfiguration during surgery.

Results: The application of this OS technique resulted in an average suspension time of 1.9 min, with no significant difference between senior and junior surgeons. The method proved more time-efficient for posterior peritoneum suspension than other published methods and showed no additional risks of organ damage, bleeding, conversion to laparotomy, or OS-related complications. The secondary outcomes revealed reduced hospital stays and minimal blood loss, highlighting the procedure's overall efficiency.

Limitations: Given its retrospective and single-center nature, the study's results may not be widely generalizable. Prospective multicentric comparative studies are recommended to further validate Angioni's technique.

Conclusions: Laparoscopic OS sec. Angioni is introduced as a straightforward, safe, and cost-effective method that significantly streamlines the surgical process. Its adaptability and ease of use suggest that it could be a valuable addition to current gynecological surgical practices, with potential implications for increasing efficiency and reducing procedural costs. Future studies are required to confirm these results across diverse clinical environments.

研究目的本研究旨在评估腹腔镜器官悬吊术秒速快三精准人工下注计划的安全性、有效性和成本效益。Angioni是一种在腹腔镜妇科手术中进行瞬时器官悬吊(OS)的创新方法。该研究认识到需要加强手术部位的通路并克服现有器官牵引方法的局限性,因此研究了一种新型的、在手术室内构建的 OS 装置:这项回顾性观察研究于 2019 年 3 月至 2021 年 5 月进行,纳入了 330 名接受多孔口或单孔口腹腔镜手术的患者,这些患者采用 Angioni 技术进行了盆腔器官短暂悬吊:参与者包括因子宫内膜异位症、卵巢癌、子宫内膜癌、盆腔脱垂和良性卵巢囊肿等疾病接受手术的患者。腹腔镜器官悬吊术(Laparoscopic Organ Suspension sec.Angioni 利用一段连接到聚乳酸(Polyglactin)缝合线的 Foley 导管提供可调节的张力,最大限度地减少了手术中重新配置的需要:结果:采用这种操作系统技术后,平均悬吊时间为 1.9 分钟,高级外科医生和初级外科医生之间没有明显差异。与其他已发表的方法相比,该方法在后腹膜悬吊方面更省时省力,而且不会增加器官损伤、出血、转为开腹手术或 OS 相关并发症的风险。次要结果显示,住院时间缩短,失血量极少,凸显了手术的整体效率:局限性:由于该研究具有回顾性和单中心性质,其结果可能无法广泛推广。建议进行前瞻性多中心比较研究,以进一步验证安吉奥尼技术:腹腔镜器官悬吊术(Laparoscopic Organ Suspension sec.结论:腹腔镜器官悬吊术是一种简单、安全、经济的方法,可显著简化手术过程。它的适应性和易用性表明,它可以成为当前妇科手术实践的重要补充,对提高效率和降低手术成本具有潜在影响。未来的研究需要在不同的临床环境中证实这些结果。
{"title":"Safety, Efficacy, and Cost-effectiveness of Organ Suspension in Laparoscopic Gynecologic Surgery: A Retrospective Cohort Study to Validate an Innovative Technique: Laparoscopic Organ Suspension sec. Angioni.","authors":"Stefano Angioni, Stefania Saponara, Gianmarco D'Ancona, Gilda Sicilia, Maurizio Nicola D'Alterio, Salvatore Giovanni Vitale","doi":"10.1159/000538787","DOIUrl":"10.1159/000538787","url":null,"abstract":"<p><strong>Objectives: </strong>This study aims to evaluate the safety, efficacy, and cost-effectiveness of the Laparoscopic Organ Suspension (OS) sec. Angioni, an innovative approach to transient OS in laparoscopic gynecological procedures. Recognizing the need to enhance surgical site access and overcome limitations of existing organ retraction methods, the study investigates a novel, in-theater constructed OS device.</p><p><strong>Design: </strong>This retrospective observational study was conducted from March 2019 to May 2021 and included 330 patients who underwent multiport or single-site-port laparoscopic surgery employing Angioni's technique for transient pelvic OS.</p><p><strong>Participants/materials, setting, methods: </strong>Participants included individuals undergoing surgery for conditions such as endometriosis, ovarian cancer, endometrial cancer, pelvic prolapse, and benign ovarian cysts. The Laparoscopic OS sec. Angioni utilizes a segment of a Foley catheter connected to a Polyglactin suture to provide adjustable tension, minimizing the need for reconfiguration during surgery.</p><p><strong>Results: </strong>The application of this OS technique resulted in an average suspension time of 1.9 min, with no significant difference between senior and junior surgeons. The method proved more time-efficient for posterior peritoneum suspension than other published methods and showed no additional risks of organ damage, bleeding, conversion to laparotomy, or OS-related complications. The secondary outcomes revealed reduced hospital stays and minimal blood loss, highlighting the procedure's overall efficiency.</p><p><strong>Limitations: </strong>Given its retrospective and single-center nature, the study's results may not be widely generalizable. Prospective multicentric comparative studies are recommended to further validate Angioni's technique.</p><p><strong>Conclusions: </strong>Laparoscopic OS sec. Angioni is introduced as a straightforward, safe, and cost-effective method that significantly streamlines the surgical process. Its adaptability and ease of use suggest that it could be a valuable addition to current gynecological surgical practices, with potential implications for increasing efficiency and reducing procedural costs. Future studies are required to confirm these results across diverse clinical environments.</p>","PeriodicalId":12952,"journal":{"name":"Gynecologic and Obstetric Investigation","volume":" ","pages":"445-452"},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140857075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polycystic Ovary Syndrome and Alteration of Vocal Function: A Systematic Review and Meta-Analysis. 多囊卵巢综合征(PCOS)与发声功能的改变:系统回顾与荟萃分析。
IF 2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-01-01 Epub Date: 2024-01-09 DOI: 10.1159/000535819
Camilla Turetta, Andrea Colizza, Andrea Giannini, Massimo Ralli, Giorgio Bogani, Antonio Simone Laganà, Francesco Pecorini, Ludovico Muzii, Antonio Paoli, Violante Di Donato, Marco De Vincentiis

Introduction: Polycystic ovary syndrome (PCOS) is a common hormonal disorder among young women, correlated with hyperandrogenism. Among the symptoms of PCOS, vocal alterations are quite unknown. Dysphonia may be related to hyperandrogenism, and there is no consensus about its prevalence and the severity of vocal disorders, which can cause noticeable discomfort.

Methods: A systematic review of the literature was conducted. Four studies on PCOS that evaluated the phonatory system were included for a total of 174 patients (96 PCOS, 78 controls), and a meta-analysis on comparable data was performed.

Results: Four studies evaluated parameters related to vocal symptomatology, altered audiometric examination, and findings at the laryngoscopy in patients affected by PCOS versus controls. Although the individual studies showed increased incidence of alterations and a tendency to develop speech fatigue in women with PCOS, when the results of studies were pulled in meta-analysis, the overall difference was not statistically significant. The studies themselves were very different from each other; therefore, it is hard to draw any firm conclusions.

Discussion: The aim of this study was to assess the prevalence of vocal alterations, the correlation with hyperandrogenism, the quality of life, and the voice changes after starting a therapy for PCOS. The present meta-analysis failed to find any difference in terms of PCOS and control cohort. However, the lack of high-quality studies makes it difficult to draw firm conclusions. New and larger studies or big population program data are therefore warranted.

导言多囊卵巢综合征(PCOS)是年轻女性中常见的内分泌失调症,与雄激素过多有关。在多囊卵巢综合征的症状中,声带改变的症状尚不为人所知。发音障碍可能与雄激素过多有关,目前对其发病率和严重程度还没有达成共识,这可能会引起明显的不适:方法:对文献进行了系统回顾。方法:对文献进行了系统性回顾,纳入了四项评估发音系统的多囊卵巢综合症研究,共计 174 名患者(96 名多囊卵巢综合症患者,78 名对照组患者),并对可比数据进行了荟萃分析:结果:四项研究评估了多囊卵巢综合症患者与对照组患者在发声症状、听力检查变化和喉镜检查结果方面的相关参数。虽然单项研究显示多囊卵巢综合症女性患者的发声改变发生率增加,并有说话疲劳的倾向,但在对研究结果进行荟萃分析时,总体差异在统计学上并不显著。这些研究本身存在很大差异,因此很难得出确切的结论:本研究的目的是评估嗓音改变的发生率、与高雄激素的相关性、生活质量以及开始治疗多囊卵巢综合症后嗓音的变化。本荟萃分析未发现多囊卵巢综合症患者与对照组之间存在任何差异。然而,由于缺乏高质量的研究,很难得出确切的结论。因此,有必要进行新的、更大规模的研究或大型人群项目数据。
{"title":"Polycystic Ovary Syndrome and Alteration of Vocal Function: A Systematic Review and Meta-Analysis.","authors":"Camilla Turetta, Andrea Colizza, Andrea Giannini, Massimo Ralli, Giorgio Bogani, Antonio Simone Laganà, Francesco Pecorini, Ludovico Muzii, Antonio Paoli, Violante Di Donato, Marco De Vincentiis","doi":"10.1159/000535819","DOIUrl":"10.1159/000535819","url":null,"abstract":"<p><strong>Introduction: </strong>Polycystic ovary syndrome (PCOS) is a common hormonal disorder among young women, correlated with hyperandrogenism. Among the symptoms of PCOS, vocal alterations are quite unknown. Dysphonia may be related to hyperandrogenism, and there is no consensus about its prevalence and the severity of vocal disorders, which can cause noticeable discomfort.</p><p><strong>Methods: </strong>A systematic review of the literature was conducted. Four studies on PCOS that evaluated the phonatory system were included for a total of 174 patients (96 PCOS, 78 controls), and a meta-analysis on comparable data was performed.</p><p><strong>Results: </strong>Four studies evaluated parameters related to vocal symptomatology, altered audiometric examination, and findings at the laryngoscopy in patients affected by PCOS versus controls. Although the individual studies showed increased incidence of alterations and a tendency to develop speech fatigue in women with PCOS, when the results of studies were pulled in meta-analysis, the overall difference was not statistically significant. The studies themselves were very different from each other; therefore, it is hard to draw any firm conclusions.</p><p><strong>Discussion: </strong>The aim of this study was to assess the prevalence of vocal alterations, the correlation with hyperandrogenism, the quality of life, and the voice changes after starting a therapy for PCOS. The present meta-analysis failed to find any difference in terms of PCOS and control cohort. However, the lack of high-quality studies makes it difficult to draw firm conclusions. New and larger studies or big population program data are therefore warranted.</p>","PeriodicalId":12952,"journal":{"name":"Gynecologic and Obstetric Investigation","volume":" ","pages":"22-30"},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139402536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health-Related Quality of Life after Hysterectomy for Endometrial Cancer: The Impact of Enhanced Recovery after Surgery Shifting Paradigm. 子宫内膜癌子宫切除术后与健康相关的生活质量:术后强化恢复(ERAS)模式转变的影响。
IF 2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-01-01 Epub Date: 2024-03-12 DOI: 10.1159/000538024
Federico Ferrari, Hooman Soleymani Majd, Andrea Giannini, Alessandro Favilli, Antonio Simone Laganà, Elisa Gozzini, Franco Odicino

Objectives: Enhanced recovery after surgery (ERAS) protocols provide well-known benefits in the immediate recovery with a shorter length of stay (LOS) and also in gynecological surgery. However, the impact of ERAS has not been clearly showed yet regarding long-term consequences and health-related quality of life (HRQL). The aim of this study was to investigate the impact of ERAS on HRQL after hysterectomy for endometrial cancer.

Design: An observational retrospective study with propensity score matching (PSM) was performed.

Participants: We administered the SF-36 validated questionnaire to women underwent hysterectomy and lymph nodal staging before and after introducing ERAS protocol, getting, respectively, a standard practice (SP) and ERAS group.

Settings: The study was conducted at the academic hospital.

Methods: We collected demographic, clinical, surgical and postoperative data and performed a PSM of the baseline confounders. We administered the questionnaire 4 weeks after the surgery. The SF-36 measures HRQL using eight scales: physical functioning (PF), role physical (RLP), bodily pain (BP), general health (GH), vitality (Vt), social functioning (SF), role emotional (RLE) and mental health (MH).

Results: After PSM, we enrolled a total of 154 patients, 77 in each group (SP and ERA). The two groups were similar in terms of age, BMI, anesthetic risk, Charlson comorbidity index (CCI), and surgical technique (minimally invasive vs. open access). Median LOS was shorter for ERAS group (5 vs. 3 days; p = 0.02), while no significant differences were registered in the rates of postoperative complications (16.9% vs. 17.4%; p = 0.66). Response rates to SF-36 questionnaire were 89% and 92%, respectively, in SP and ERAS group. At multivariate analyzes, the mean scores of SF-36 questionnaire, registered at 28 days weeks after surgery (range 26-32 days), were significantly higher in ERAS group for PF (73.3 vs. 91.6; p < 0.00), RLP (median 58.3 vs. 81.2; p = 0.02), and SF (37.5 vs. 58.3; p = 0.01) domains, when compared to SP patients.

Limitations: Further follow-up was not possible due to the anonymized data derived from clinical audit.

Conclusions: ERAS significantly increases the HRQL of women who underwent surgery for endometrial cancer. HRQL assessment should be routinely implemented in the ERAS protocol.

目的:众所周知,加强术后恢复(ERAS)方案可以缩短妇科手术的住院时间(LOS),促进即时恢复。然而,ERAS 对长期后果和健康相关生活质量(HRQL)的影响尚未明确显示出来。本研究旨在调查 ERAS 对子宫内膜癌子宫切除术后 HRQL 的影响:设计:观察性回顾研究,倾向得分匹配(PSM)。方法 我们收集了人口统计学、临床、手术和术后数据,并对基线Coufouders进行了倾向得分匹配(PSM)。我们在术后四周进行了问卷调查。SF-36 使用八个量表测量 HRQL:身体功能(PF)、角色身体(RLP)、身体疼痛(BP)、一般健康(GH)、活力(Vt)、社会功能(SF)、角色情感(RLE)和心理健康(MH)。结果 PSM 后,我们共招募了 154 名患者,每组 77 人(SP 和 ERA)。两组患者在年龄、体重指数、麻醉风险、查尔森合并症指数(CCI)和手术技术(微创与开放入路)方面相似。ERAS组的中位住院日较短(5天对3天;P = 0.02),术后并发症发生率无明显差异(16.9%对17.4%;P = 0.66)。SP组和ERAS组的SF-36调查问卷回复率分别为89%和92%。在多变量分析中,与SP患者相比,ERAS组患者在术后28周(26-32天)的SF-36调查问卷平均得分在PF(73.3 vs 91.6;p < 0.00)、RLP(中位数58.3 vs 81.2;p = 0.02)和SF(37.5 vs 58.3;p = 0.01)领域明显更高。局限性 由于临床审计数据为匿名数据,因此无法进行进一步随访。结论 ERAS能明显提高接受子宫内膜癌手术妇女的 HRQL。ERAS方案中应常规实施HRQL评估。
{"title":"Health-Related Quality of Life after Hysterectomy for Endometrial Cancer: The Impact of Enhanced Recovery after Surgery Shifting Paradigm.","authors":"Federico Ferrari, Hooman Soleymani Majd, Andrea Giannini, Alessandro Favilli, Antonio Simone Laganà, Elisa Gozzini, Franco Odicino","doi":"10.1159/000538024","DOIUrl":"10.1159/000538024","url":null,"abstract":"<p><strong>Objectives: </strong>Enhanced recovery after surgery (ERAS) protocols provide well-known benefits in the immediate recovery with a shorter length of stay (LOS) and also in gynecological surgery. However, the impact of ERAS has not been clearly showed yet regarding long-term consequences and health-related quality of life (HRQL). The aim of this study was to investigate the impact of ERAS on HRQL after hysterectomy for endometrial cancer.</p><p><strong>Design: </strong>An observational retrospective study with propensity score matching (PSM) was performed.</p><p><strong>Participants: </strong>We administered the SF-36 validated questionnaire to women underwent hysterectomy and lymph nodal staging before and after introducing ERAS protocol, getting, respectively, a standard practice (SP) and ERAS group.</p><p><strong>Settings: </strong>The study was conducted at the academic hospital.</p><p><strong>Methods: </strong>We collected demographic, clinical, surgical and postoperative data and performed a PSM of the baseline confounders. We administered the questionnaire 4 weeks after the surgery. The SF-36 measures HRQL using eight scales: physical functioning (PF), role physical (RLP), bodily pain (BP), general health (GH), vitality (Vt), social functioning (SF), role emotional (RLE) and mental health (MH).</p><p><strong>Results: </strong>After PSM, we enrolled a total of 154 patients, 77 in each group (SP and ERA). The two groups were similar in terms of age, BMI, anesthetic risk, Charlson comorbidity index (CCI), and surgical technique (minimally invasive vs. open access). Median LOS was shorter for ERAS group (5 vs. 3 days; p = 0.02), while no significant differences were registered in the rates of postoperative complications (16.9% vs. 17.4%; p = 0.66). Response rates to SF-36 questionnaire were 89% and 92%, respectively, in SP and ERAS group. At multivariate analyzes, the mean scores of SF-36 questionnaire, registered at 28 days weeks after surgery (range 26-32 days), were significantly higher in ERAS group for PF (73.3 vs. 91.6; p &lt; 0.00), RLP (median 58.3 vs. 81.2; p = 0.02), and SF (37.5 vs. 58.3; p = 0.01) domains, when compared to SP patients.</p><p><strong>Limitations: </strong>Further follow-up was not possible due to the anonymized data derived from clinical audit.</p><p><strong>Conclusions: </strong>ERAS significantly increases the HRQL of women who underwent surgery for endometrial cancer. HRQL assessment should be routinely implemented in the ERAS protocol.</p>","PeriodicalId":12952,"journal":{"name":"Gynecologic and Obstetric Investigation","volume":" ","pages":"304-310"},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140109866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Gynecologic and Obstetric Investigation
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1